Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer

[1]  David G. E. Smith,et al.  Immunomodulation of Host Chitinase 3-Like 1 During a Mammary Pathogenic Escherichia coli Infection , 2018, Front. Immunol..

[2]  M. Merad,et al.  Macrophages orchestrate breast cancer early dissemination and metastasis , 2018, Nature Communications.

[3]  K. Janes,et al.  Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer. , 2017, Developmental cell.

[4]  T. Vanden Berghe,et al.  Preconditioning with Lipopolysaccharide or Lipoteichoic Acid Protects against Staphylococcus aureus Mammary Infection in Mice , 2017, Front. Immunol..

[5]  C. Denkert,et al.  Molecular alterations in triple-negative breast cancer—the road to new treatment strategies , 2017, The Lancet.

[6]  N. Erez,et al.  Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1 , 2017, Oncogene.

[7]  Xiaobo Zhang,et al.  Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein , 2017, Journal of Hematology & Oncology.

[8]  F. Kittrell,et al.  Macrophages promote the progression of premalignant mammary lesions to invasive cancer , 2017, Oncotarget.

[9]  I. Mellman,et al.  Elements of cancer immunity and the cancer–immune set point , 2017, Nature.

[10]  J. Larkin,et al.  Vessel co‐option is common in human lung metastases and mediates resistance to anti‐angiogenic therapy in preclinical lung metastasis models , 2016, The Journal of pathology.

[11]  Shou-Ching Tang,et al.  Immunotherapy for breast cancer: past, present, and future , 2016, Cancer and Metastasis Reviews.

[12]  G. MacGrogan,et al.  The mammary ducts create a favourable microenvironment for xenografting of luminal and molecular apocrine breast tumours , 2016, The Journal of pathology.

[13]  O. De Wever,et al.  Comparison of the Adipose and Luminal Mammary Gland Compartment as Orthotopic Inoculation Sites in a 4T1-Based Immunocompetent Preclinical Model for Triple-Negative Breast Cancer , 2016, Journal of Mammary Gland Biology and Neoplasia.

[14]  H. Kohrt,et al.  Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer. , 2016, Cancer research.

[15]  R. Gomis,et al.  Tumour stroma‐derived lipocalin‐2 promotes breast cancer metastasis , 2016, The Journal of pathology.

[16]  H. Kohrt,et al.  Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  B. Brüne,et al.  Lipocalin 2 from macrophages stimulated by tumor cell–derived sphingosine 1-phosphate promotes lymphangiogenesis and tumor metastasis , 2016, Science Signaling.

[18]  Nicolò Riggi,et al.  Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors , 2016, Oncotarget.

[19]  V. Péton,et al.  Disruption of the sigS gene attenuates the local innate immune response to Staphylococcus aureus in a mouse mastitis model. , 2016, Veterinary microbiology.

[20]  Wassim Raffoul,et al.  A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response. , 2016, Cancer cell.

[21]  E. Yeh,et al.  Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy , 2016, npj Breast Cancer.

[22]  N. Brady,et al.  Macrophages: Regulators of the Inflammatory Microenvironment during Mammary Gland Development and Breast Cancer , 2016, Mediators of inflammation.

[23]  J. Thiery,et al.  Contact-dependent carcinoma aggregate dispersion by M2a macrophages via ICAM-1 and β2 integrin interactions , 2015, Oncotarget.

[24]  L. Pan,et al.  Macrophages Support Splenic Erythropoiesis in 4T1 Tumor-Bearing Mice , 2015, PloS one.

[25]  P. Vandenabeele,et al.  Non-Classical ProIL-1beta Activation during Mammary Gland Infection Is Pathogen-Dependent but Caspase-1 Independent , 2014, PloS one.

[26]  S. Libreros,et al.  CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factors , 2013, Immunologic Research.

[27]  Tingmei Chen,et al.  Hydrazinocurcumin Encapsuled Nanoparticles “Re-Educate” Tumor-Associated Macrophages and Exhibit Anti-Tumor Effects on Breast Cancer Following STAT3 Suppression , 2013, PloS one.

[28]  Y. Shibata,et al.  Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: Decreased tumor metastasis in a breast cancer model , 2012, International journal of cancer.

[29]  F. Kittrell,et al.  Intra-mammary Ductal Transplantation: A Tool to Study Premalignant Progression , 2012, Journal of Mammary Gland Biology and Neoplasia.

[30]  Jong Hoon Park,et al.  Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model , 2012, Breast Cancer Research.

[31]  H. Cho,et al.  Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model , 2012, Breast Cancer Research.

[32]  G. M. Nagaraja,et al.  A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease , 2012, BMC Cancer.

[33]  William P. Smith,et al.  Human primary ductal carcinoma in situ (DCIS) subtype‐specific pathology is preserved in a mouse intraductal (MIND) xenograft model , 2011, The Journal of pathology.

[34]  S. Leung,et al.  Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. , 2011, Cancer research.

[35]  Ash A. Alizadeh,et al.  Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma , 2010, Cell.

[36]  C. Liu,et al.  The Role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression , 2009, Oncogene.

[37]  L. Pusztai,et al.  Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. , 2009, Cancer research.

[38]  I. Papassotiriou,et al.  Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease , 2009, BMC Cancer.

[39]  F. Kittrell,et al.  An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ , 2009, Breast Cancer Research.

[40]  Margaret Sutcliffe,et al.  Epithelial–mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[41]  Joseph,et al.  Imagable 4T1 model for the study of late stage breast cancer , 2008, BMC Cancer.

[42]  A. Friedl,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer , 2008, Breast Cancer Research and Treatment.

[43]  A. Sica,et al.  Plasticity of Macrophage Function during Tumor Progression: Regulation by Distinct Molecular Mechanisms1 , 2008, The Journal of Immunology.

[44]  J. Jonkers,et al.  Modeling Metastatic Breast Cancer in Mice , 2007, Journal of Mammary Gland Biology and Neoplasia.

[45]  K. Hunter,et al.  Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. , 2007, Experimental and molecular pathology.

[46]  Gerhard Christofori,et al.  Mouse models of breast cancer metastasis , 2006, Breast Cancer Research.

[47]  P. Schedin.  Pregnancy-associated breast cancer and metastasis , 2006, Nature Reviews Cancer.

[48]  D. Nielsen,et al.  Serum YKL-40, A New Prognostic Biomarker in Cancer Patients? , 2006, Cancer Epidemiology Biomarkers & Prevention.

[49]  J. Pollard,et al.  Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.

[50]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[51]  M. Brigden,et al.  Macrophage‐tumor cell associations: a factor in metastasis of breast cancer? , 1993, Journal of leukocyte biology.

[52]  M. Alsharedi,et al.  Immunotherapy in triple-negative breast cancer , 2017, Medical Oncology.

[53]  Megan Troxell,et al.  TUMORIGENESIS AND NEOPLASTIC PROGRESSION Myoepithelial Cell Differentiation Markers in Ductal Carcinoma in Situ Progression , 2015 .

[54]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[55]  Meenakshi Singh,et al.  Tumorigenesis and Neoplastic Progression Remodeling of the Mammary Microenvironment after Lactation Promotes Breast Tumor Cell Metastasis , 2022 .